Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12601107rdf:typepubmed:Citationlld:pubmed
pubmed-article:12601107lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:12601107lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:12601107lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:12601107lifeskim:mentionsumls-concept:C0175723lld:lifeskim
pubmed-article:12601107lifeskim:mentionsumls-concept:C0133821lld:lifeskim
pubmed-article:12601107pubmed:issue4lld:pubmed
pubmed-article:12601107pubmed:dateCreated2003-2-25lld:pubmed
pubmed-article:12601107pubmed:abstractTextOligoclonal IgG bands (OCB) are present in most patients with MS in Western countries; however, in Japanese MS patients, the OCB-positive rate is not as high. A relationship between immunogenetic backgrounds, namely, human leukocyte antigen (HLA) DR2 and DR4 positivity, and OCB production in MS patients from Hokkaido, the northernmost island of Japan, has been previously suggested by the authors.lld:pubmed
pubmed-article:12601107pubmed:languageenglld:pubmed
pubmed-article:12601107pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12601107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601107pubmed:statusMEDLINElld:pubmed
pubmed-article:12601107pubmed:monthFeblld:pubmed
pubmed-article:12601107pubmed:issn1526-632Xlld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:KikuchiSSlld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:HamadaTTlld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:TashiroKKlld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:YabuYYlld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:FukazawaTTlld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:MiyagishiRRlld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:HashimotoS...lld:pubmed
pubmed-article:12601107pubmed:authorpubmed-author:NiinoMMlld:pubmed
pubmed-article:12601107pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12601107pubmed:day25lld:pubmed
pubmed-article:12601107pubmed:volume60lld:pubmed
pubmed-article:12601107pubmed:ownerNLMlld:pubmed
pubmed-article:12601107pubmed:authorsCompleteYlld:pubmed
pubmed-article:12601107pubmed:pagination647-51lld:pubmed
pubmed-article:12601107pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:meshHeadingpubmed-meshheading:12601107...lld:pubmed
pubmed-article:12601107pubmed:year2003lld:pubmed
pubmed-article:12601107pubmed:articleTitleHLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen.lld:pubmed
pubmed-article:12601107pubmed:affiliationDepartment of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. skikuti@med.hokudai.ac.jplld:pubmed
pubmed-article:12601107pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12601107pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed